The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging
Top Cited Papers
Open Access
- 16 January 2021
- Vol. 10 (1), 174
- https://doi.org/10.3390/cells10010174
Abstract
According to the WHO, 38 million individuals were living with human immunodeficiency virus (HIV), 25.4 million of which were using antiretroviral therapy (ART) at the end of 2019. Despite ART-mediated suppression of viral replication, ART is not a cure and is associated with viral persistence, residual inflammation, and metabolic disturbances. Indeed, due to the presence of viral reservoirs, lifelong ART therapy is required to control viremia and prevent disease progression into acquired immune deficiency syndrome (AIDS). Successful ART treatment allows people living with HIV (PLHIV) to achieve a similar life expectancy to uninfected individuals. However, recent studies have illustrated the presence of increased comorbidities, such as accelerated, premature immune aging, in ART-controlled PLHIV compared to uninfected individuals. Studies suggest that both HIV-infection and ART-treatment lead to mitochondrial dysfunction, ultimately resulting in cellular exhaustion, senescence, and apoptosis. Since mitochondria are essential cellular organelles for energy homeostasis and cellular metabolism, their compromise leads to decreased oxidative phosphorylation (OXPHOS), ATP synthesis, gluconeogenesis, and beta-oxidation, abnormal cell homeostasis, increased oxidative stress, depolarization of the mitochondrial membrane potential, and upregulation of mitochondrial DNA mutations and cellular apoptosis. The progressive mitochondrial damage induced by HIV-infection and ART-treatment likely contributes to accelerated aging, senescence, and cellular dysfunction in PLHIV. This review discusses the connections between mitochondrial compromise and cellular dysfunction associated with HIV- and ART-induced toxicities, providing new insights into how HIV and current ART directly impact mitochondrial functions and contribute to cellular senescence and aging in PLHIV. Identifying this nexus and potential mechanisms may be beneficial in developing improved therapeutics for treating PLHIV.Keywords
Funding Information
- National Institutes of Health (R01AI114748, R21AI138598)
- U.S. Department of Veterans Affairs (1I01BX002670, 1I01BX004281)
- U.S. Department of Defense (PR170067)
This publication has 176 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Anti-apoptotic mechanisms of HIV: lessons and novel approaches to curing HIVCellular and Molecular Life Sciences, 2012
- Redefining the Viral Reservoirs that Prevent HIV-1 EradicationImmunity, 2012
- The HIV-1 Env Protein: A Coat of Many ColorsCurrent HIV/AIDS Reports, 2012
- Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1α to exercise trainingAGE, 2011
- Telomere dysfunction induces metabolic and mitochondrial compromiseNature, 2011
- Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cellsAtherosclerosis, 2010
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 2009
- Mitochondrial DNA repair in aging and diseaseMechanisms of Ageing and Development, 2008
- Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins?Cell, 2008